The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth

British Journal of Pharmacology

Volumn 168, Issue 2, 2013, Pages 296-317

  Drawnel, Faye M ^a   Archer, Caroline R ^a   Roderick, H Llewelyn ^a,b  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

calcium; contraction; endothelin; hypertrophy; kinase; myocyte

Indexed keywords

AMBRISENTAN; BOSENTAN; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CHANNEL L TYPE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HISTONE DEACETYLASE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOCYTE ENHANCER FACTOR 2; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITIDE 3; SODIUM CALCIUM EXCHANGE PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TRANSCRIPTION FACTOR NFATC2; TRANSCRIPTION FACTOR NFATC3; TRANSCRIPTION FACTOR NFATC4; UNCLASSIFIED DRUG;

ANGIOGENESIS; AUTOCRINE EFFECT; BIOSYNTHESIS; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CONGESTIVE HEART FAILURE; DRUG ACTIVITY; DRUG WITHDRAWAL; ENZYME ACTIVATION; HEART DEVELOPMENT; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; LIFESTYLE; LIVER TOXICITY; LOW DRUG DOSE; MUSCLE CELL; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; SINUS NODE; TREATMENT FAILURE; WEIGHT REDUCTION;

ANIMALS; CALCIUM; CARDIOMEGALY; ENDOTHELIN-1; HEART; HUMANS; MYOCARDIAL CONTRACTION; PROTEIN KINASES; RECEPTORS, ENDOTHELIN; VENTRICULAR REMODELING;

EID: 84871585276     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02195.x     Document Type: Review

References (275)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164: 1-2.
2. Allen BG, Phuong LL, Farhat H, Chevalier D, (2003). Both endothelin-A and endothelin-B receptors are present on adult rat cardiac ventricular myocytes. Can J Physiol Pharmacol 81: 95-104.
3. Alvarez BV, Pérez NG, Ennis IL, Camiliõn de Hurtado MC, Cingolani HE, (1999). Mechanisms underlying the increase in force and Ca(2+) transient that follow stretch of cardiac muscle: a possible explanation of the Anrep effect. Circ Res 85: 716-722.
4. Anand I, McMurray J, Cohn JN, Konstam MA, Notter T, Quitzau K, et al,. (2004). Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet 364: 347-354.
5. Anderson ME, (2005). Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias. Pharmacol Ther 106: 39-55.
6. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S, (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732.
7. Arai M, Yoguchi A, Iso T, Takahashi T, Imai S, Murata K, et al,. (1995). Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am J Physiol 268: H2084-H2091.
8. Aramori I, Nakanishi S, (1992). Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 267: 12468-12474.
9. Attinà T, Camidge R, Newby DE, Webb DJ, (2005). Endothelin antagonism in pulmonary hypertension, heart failure, and beyond. Heart 91: 825-831.
10. Backs J, Backs T, Bezprozvannaya S, McKinsey TA, Olson EN, (2008). Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol Cell Biol 28: 3437-3445.
11. Ballard C, Schaffer S, (1996). Stimulation of the Na+/Ca2+ exchanger by phenylephrine, angiotensin II and endothelin 1. J Mol Cell Cardiol 28: 11-17.
12. Baltogiannis GG, Tsalikakis DG, Mitsi AC, Hatzistergos KE, Elaiopoulos D, Fotiadis DI, et al,. (2005). Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats. Cardiovasc Res 67: 647-654.
13. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA, (2007). Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol 293: H1883-H1891.
14. van Berlo JH, Elrod JW, Aronow BJ, Pu WT, Molkentin JD, (2011). Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 108: 12331-12336.
15. Bers DM, (2002). Cardiac excitation-contraction coupling. Nature 415: 198-205.
16. Bers DM, (2006). Altered cardiac myocyte Ca regulation in heart failure. Physiology 21: 380-387.
17. Bianchini L, L'Allemain G, Pouyssegur J, (1997). The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE1 isoform) in response to growth factors. J Biol Chem 272: 271-279.
18. Biernacka A, Frangogiannis NG, (2011). Aging and cardiac fibrosis. Aging Dis 2: 158-173.
19. Bkaily G, Avedanian L, Al-Khoury J, Provost C, Nader M, D'Orléans-Juste P, et al,. (2011). Nuclear membrane receptors for ET-1 in cardiovascular function. Am J Physiol Regul Integr Comp Physiol 300: R251-R263.
20. Bogoyevitch MA, Parker PJ, Sugden PH, (1993). Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res 72: 757-767.
21. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, et al,. (1994). Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 269: 1110-1119.
22. Boivin B, Chevalier D, Villeneuve LR, Rousseau E, Allen BG, (2003). Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem 278: 29153-29163.
23. Boixel C, Dinanian S, Lang-Lazdunski L, Mercadier JJ, Hatem SN, (2001). Characterization of effects of endothelin-1 on the L-type Ca2+ current in human atrial myocytes. Am J Physiol 281: H764-H773.
24. Bootman MD, Harzheim D, Smyrnias I, Conway SJ, Roderick HL, (2007). Temporal changes in atrial EC-coupling during prolonged stimulation with endothelin-1. Cell Calcium 42: 489-501.
25. Bossuyt J, Chang C-W, Helmstadter K, Kunkel MT, Newton AC, Campbell KS, et al,. (2011). Spatiotemporally distinct protein kinase D activation in adult cardiomyocytes in response to phenylephrine and endothelin. J Biol Chem 286: 33390-33400.
26. Bourajjaj M, Armand A-S, da, Costa Martins PA, Weijts B, van der, Nagel R, Heeneman S, et al,. (2008). NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem 283: 22295-22303.
27. Bowling N, Walsh RA, Song G, Estridge T, Sandusky GE, Fouts RL, et al,. (1999). Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 99: 384-391.
28. Boyden PA, Dun W, Barbhaiya C, Ter Keurs HE, (2004). 2APB- and JTV519(K201)-sensitive micro Ca2+ waves in arrhythmogenic Purkinje cells that survive in infarcted canine heart. Heart Rhythm 1: 218-226.
29. Braz JC, Bueno OF, De Windt LJ, Molkentin JD, (2002). PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2). J Cell Biol 156: 905-919.
30. Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, et al,. (2003). Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J Clin Invest 111: 1475-1486.
31. Bueno OF, Molkentin JD, (2002). Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91: 776-781.
32. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, et al,. (2000). The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19: 6341-6350.
33. Chang S, McKinsey TA, Zhang CL, Richardson JA, Hill JA, Olson EN, (2004). Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24: 8467-8476.
34. Chen PP, Patel JR, Rybakova IN, Walker JW, Moss RL, (2010). Protein kinase A-induced myofilament desensitization to Ca(2+) as a result of phosphorylation of cardiac myosin-binding protein C. J Gen Physiol 136: 615-627.
35. Chen R, Valencia I, Zhong F, McColl KS, Roderick HL, Bootman MD, et al,. (2004). Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J Cell Biol 166: 193-203.
36. Cheng TH, Chang CY, Wei J, Lin CI, (1995). Effects of endothelin 1 on calcium and sodium currents in isolated human cardiac myocytes. Can J Physiol Pharmacol 73: 1774-1783.
37. Cheng TH, Shih NL, Chen SY, Wang DL, Chen JJ, (1999). Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res 41: 654-662.
38. Choukroun G, Hajjar R, Kyriakis JM, Bonventre JV, Rosenzweig A, Force T, (1998). Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. J Clin Invest 102: 1311-1320.
39. Choukroun G, Hajjar R, Fry S, del Monte F, Haq S, Guerrero JL, et al,. (1999). Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. J Clin Invest 104: 391-398.
40. Chow CW, Rincon M, Cavanagh J, Dickens M, Davis RJ, (1997). Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 278: 1638-1641.
41. Chun M, Liyanage UK, Lisanti MP, Lodish HF, (1994). Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci USA 91: 11728-11732.
42. Chun M, Lin HY, Henis YI, Lodish HF, (1995). Endothelin-induced endocytosis of cell surface ETA receptors. Endothelin remains intact and bound to the ETA receptor. J Biol Chem 270: 10855-10860.
43. Chung KY, Kang M, Walker JW, (2008). Contractile regulation by overexpressed ETA requires intact T tubules in adult rat ventricular myocytes. Am J Physiol 294: H2391-H2399.
44. Cingolani H, Ennis I, Aiello E, Pérez N, (2011). Role of autocrine/paracrine mechanisms in response to myocardial strain. Pflugers Arch 462: 29-38.
45. Cingolani HE, Ennis IL, (2007). Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. Circulation 115: 1090-1100.
46. Cingolani HE, Pérez NG, Caldiz CI, Garciarena CD, Giusti VC, Correa MV, et al,. (2010). Early hypertrophic signals after myocardial stretch. Role of reactive oxygen species and the sodium/hydrogen exchanger. In:, Kamkin A, Kiseleva I, (eds). Mechanosensitivity of the Heart. Springer Netherlands: Houten, pp. 327-371.
47. Clerk A, Sugden PH, (1997). Regulation of phospholipases C and D in rat ventricular myocytes: stimulation by endothelin-1, bradykinin and phenylephrine. J Mol Cell Cardiol 29: 1593-1604.
48. Clerk A, Bogoyevitch MA, Anderson MB, Sugden PH, (1994). Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem 269: 32848-32857.
49. Clerk A, Bogoyevitch MA, Fuller SJ, Lazou A, Parker PJ, Sugden PH, (1995). Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol 269: H1087-H1097.
50. Clipstone NA, Crabtree GR, (1992). Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357: 695-697.
51. Coura JR, Borges-Pereira J, (2010). Chagas disease: 100 years after its discovery. A systemic review. Acta Trop 115: 5-13.
52. Coura JR, Viñas PA, (2010). Chagas disease: a new worldwide challenge. Nature 465: S6-S7.
53. Cowburn PJ, Cleland JGF, McDonagh TA, McArthur JD, Dargie HJ, Morton JJ, (2005). Comparison of selective ET(A) and ET(B) receptor antagonists in patients with chronic heart failure. Eur J Heart Fail 7: 37-42.
54. Cuello F, Bardswell SC, Haworth RS, Yin X, Lutz S, Wieland T, et al,. (2007a). Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circ Res 100: 864-873.
55. Cuello F, Snabaitis AK, Cohen MS, Taunton J, Avkiran M, (2007b). Evidence for direct regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK): effects of the novel and specific RSK inhibitor fmk on responses to alpha1-adrenergic stimulation. Mol Pharmacol 71: 799-806.
56. Cuello F, Bardswell SC, Haworth RS, Ehler E, Sadayappan S, Kentish JC, et al,. (2011). Novel role for p90 ribosomal S6 kinase in the regulation of cardiac myofilament phosphorylation. J Biol Chem 286: 5300-5310.
57. Cullingford TE, Markou T, Fuller SJ, Giraldo A, Pikkarainen S, Zoumpoulidou G, et al,. (2008). Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes. Genome Biol 9: R32.
58. De Giusti VC, Correa MV, Villa-Abrille MC, Beltrano C, Yeves AM, de, Cingolani GEC, et al,. (2008). The positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen species. Life Sci 83: 264-271.
59. Diedrichs H, Chi M, Boelck B, Mehlhorn U, Schwinger RH, (2004). Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur J Heart Fail 6: 3-9.
60. Diwan A, Dorn GW, (2007). Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology 22: 56-64.
61. Domeier TL, Zima AV, Maxwell JT, Huke S, Mignery GA, Blatter LA, (2008). IP3 receptor-dependent Ca2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes. Am J Physiol 294: H596-H604.
62. Dupuis J, Goresky CA, Fournier A, (1996). Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol 81: 1510-1515.
63. Eguchi S, Hirata Y, Marumo F, (1993a). Endothelin subtype B receptors are coupled to adenylate cyclase via inhibitory G protein in cultured bovine endothelial cells. J Cardiovasc Pharmacol 22 (Suppl. 8): S161-S163.
64. Eguchi S, Hirata Y, Imai T, Marumo F, (1993b). Endothelin receptor subtypes are coupled to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature. Endocrinology 132: 524-529.
65. El-Mowafy AM, White RE, (1999). Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS Lett 451: 63-67.
66. Erdbrugger W, Keffel J, Knocks M, Otto T, Philipp T, Michel MC, (1997). Protein kinase C isoenzymes in rat and human cardiovascular tissues. Br J Pharmacol 120: 177-186.
67. Ergul A, Grubbs AL, Zhang Y, Spinale FG, (2000a). Selective upregulation of endothelin converting enzyme-1a in the human failing heart. J Card Fail 6: 314-320.
68. Ergul A, Walker CA, Goldberg A, Baicu SC, Hendrick JW, King MK, et al,. (2000b). ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression. Am J Physiol 278: H2050-H2056.
69. Evans NJ, Walker JW, (2008a). Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J 95: 483-492.
70. Evans NJ, Walker JW, (2008b). Sustained Ca2+ signaling and delayed internalization associated with endothelin receptor heterodimers linked through a PDZ finger. Can J Physiol Pharmacol 86: 526-535.
71. Fabiato A, (1983). Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 245: C1-C14.
72. Fearnley CJ, Roderick HL, Bootman MD, (2011). Calcium signaling in cardiac myocytes. Cold Spring Harb Perspect Biol 3: a004242.
73. Filtz TM, Grubb DR, McLeod-Dryden TJ, Luo J, Woodcock EA, (2009). Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase Cbeta1b. FASEB J 23: 3564-3570.
74. Firth JD, Ratcliffe PJ, (1992). Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest 90: 1023-1031.
75. Fliegel L, Karmazyn M, (2004). The cardiac Na-H exchanger: a key downstream mediator for the cellular hypertrophic effects of paracrine, autocrine and hormonal factors. Biochem Cell Biol 82: 626-635.
76. Francis G, Benedict C, Johnstone D, Kirlin P, Nicklas J, Liang C, et al,. (1990). Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724-1729.
77. Freedman NJ, Ament AS, Oppermann M, Stoffel RH, Exum ST, Lefkowitz RJ, (1997). Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity. J Biol Chem 272: 17734-17743.
78. Fruman DA, Klee CB, Bierer BE, Burakoff SJ, (1992). Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci USA 89: 3686-3690.
79. Fujisaki H, Ito H, Hirata Y, Tanaka M, Hata M, Lin M, et al,. (1995). Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest 96: 1059-1065.
80. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M, (2000). Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933.
81. Gilbert JC, Shirayama T, Pappano AJ, (1991). Inositol trisphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ Res 69: 1632-1639.
82. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR, (1995). Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 95: 888-894.
83. Gohla A, Offermanns S, Wilkie TM, Schultz G, (1999). Differential involvement of Galpha12 and Galpha13 in receptor-mediated stress fiber formation. J Biol Chem 274: 17901-17907.
84. Gomberg-Maitland M, Dufton C, Oudiz RJ, Benza RL, (2011). Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective. J Am Coll Cardiol 57: 1053-1061.
85. Gomez del Arco P, Martinez-Martinez S, Maldonado JL, Ortega-Perez I, Redondo JM, (2000). A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp. J Biol Chem 275: 13872-13878.
86. Goonasekera SA, Molkentin JD, (2012). Unraveling the secrets of a double life: contractile versus signaling Ca2+ in a cardiac myocyte. J Mol Cell Cardiol 52: 317-322.
87. Gorza L, Schiaffino S, Volpe P, (1993). Inositol 1,4,5-trisphosphate receptor in heart: evidence for its concentration in Purkinje myocytes of the conduction system. J Cell Biol 121: 345-353.
88. Griendling KK, Tsuda T, Alexander RW, (1989). Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. J Biol Chem 264: 8237-8240.
89. Hallhuber M, Burkard N, Wu R, Buch MH, Engelhardt S, Hein L, et al,. (2006). Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy. Circ Res 99: 626-635.
90. Harris IS, Zhang S, Treskov I, Kovacs A, Weinheimer C, Muslin AJ, (2004). Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload. Circulation 110: 718-723.
91. Harzheim D, Movassagh M, Foo RS, Ritter O, Tashfeen A, Conway SJ, et al,. (2009). Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy. Proc Natl Acad Sci USA 106: 11406-11411.
92. Harzheim D, Talasila A, Movassagh M, Foo RS, Figg N, Bootman MD, et al,. (2010). Elevated InsP3R expression underlies enhanced calcium fluxes and spontaneous extra-systolic calcium release events in hypertrophic cardiac myocytes. Channels (Austin) 4: 67-71.
93. Hasegawa K, Fujiwara H, Koshiji M, Inada T, Ohtani S, Doyama K, et al,. (1996). Endothelin-1 and its receptor in hypertrophic cardiomyopathy. Hypertension 27: 259-264.
94. Hautala N, Tokola H, Luodonpaa M, Puhakka J, Romppanen H, Vuolteenaho O, et al,. (2001). Pressure overload increases GATA4 binding activity via endothelin-1. Circulation 103: 730-735.
95. Hautala N, Tenhunen O, Szokodi I, Ruskoaho H, (2002). Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways. Pflugers Arch 443: 362-369.
96. He JQ, Pi Y, Walker JW, Kamp TJ, (2000). Endothelin-1 and photoreleased diacylglycerol increase L-type Ca2+ current by activation of protein kinase C in rat ventricular myocytes. J Physiol (Lond) 524 (Pt 3): 807-820.
97. Heinzel FR, MacQuaide N, Biesmans L, Sipido K, (2011). Dyssynchrony of Ca2+ release from the sarcoplasmic reticulum as subcellular mechanism of cardiac contractile dysfunction. J Mol Cell Cardiol 50: 390-400.
98. Higazi DR, Fearnley CJ, Drawnel FM, Talasila A, Corps EM, Ritter O, et al,. (2009). Endothelin-1-stimulated InsP3-induced Ca2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol Cell 33: 472-482.
99. Hilal-Dandan R, Ramirez MT, Villegas S, Gonzalez A, Endo-Mochizuki Y, Brown JH, et al,. (1997). Endothelin ETA receptor regulates signaling and ANF gene expression via multiple G protein-linked pathways. Am J Physiol 272: H130-H137.
100. Hirata Y, Fukuda Y, Yoshimi H, Emori T, Shichiri M, Marumo F, (1989). Specific receptor for endothelin in cultured rat cardiocytes. Biochem Biophys Res Commun 160: 1438-1444.
101. Hirose M, Stuyvers B, Dun W, Ter Keurs HE, Boyden PA, (2008). Wide long lasting perinuclear Ca2+ release events generated by an interaction between ryanodine and IP3 receptors in canine Purkinje cells. J Mol Cell Cardiol 45: 176-184.
102. Hogan PG, Chen L, Nardone J, Rao A, (2003). Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17: 2205-2232.
103. Hosoda K, Nakao K, Arai H, Suga S, Ogawa Y, Mukoyama M, et al,. (1991). Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett 287: 23-26.
104. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al,. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863-2867.
105. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T, (1988a). Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch 413: 108-110.
106. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T, (1988b). Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 255: H970-H973.
107. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, et al,. (1991). Endothelin-1 induces hypertrophy with enhanced expression of muscle- specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69: 209-215.
108. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, et al,. (1993). Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92: 398-403.
109. Ito H, Hiroe M, Hirata Y, Fujisaki H, Adachi S, Akimoto H, et al,. (1994). Endothelin ET(A) receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 89: 2198-2203.
110. Jain J, Miner Z, Rao A, (1993). Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J Immunol 151: 837-848.
111. Jasmin JF, Cernacek P, Dupuis J, (2003). Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade. Clin Sci (Lond) 105: 647-653.
112. Jessup M, Brozena S, (2003). Heart failure. N Engl J Med 348: 2007-2018.
113. Ju Y-K, Liu J, Lee BH, Lai D, Woodcock EA, Lei M, et al,. (2011). Distribution and functional role of inositol 1,4,5-trisphosphate receptors in mouse sinoatrial node. Circ Res 109: 848-857.
114. Kakita T, Hasegawa K, Iwai-Kanai E, Adachi S, Morimoto T, Wada H, et al,. (2001). Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res 88: 1239-1246.
115. Kalra PR, Moon JC, Coats AJ, (2002). Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? Int J Cardiol 85: 195-197.
116. Kamp TJ, Hell JW, (2000). Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87: 1095-1102.
117. Kapur N, Banach K, (2007). Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes. J Physiol (Lond) 581: 1113-1127.
118. Karagueuzian HS, (2011). Targeting cardiac fibrosis: a new frontier in antiarrhythmic therapy? Am J Cardiovasc Dis 1: 101-109.
119. Kawamura T, Ono K, Morimoto T, Akao M, Iwai-Kanai E, Wada H, et al,. (2004). Endothelin-1-dependent nuclear factor of activated T lymphocyte signaling associates with transcriptional coactivator p300 in the activation of the B cell leukemia-2 promoter in cardiac myocytes. Circ Res 94: 1492-1499.
120. Kedzierski RM, Yanagisawa M, (2001). Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41: 851-876.
121. Kehat I, Molkentin JD, (2010). Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Ann N Y Acad Sci 1188: 96-102.
122. Kehat I, Davis J, Tiburcy M, Accornero F, Saba-El-Leil MK, Maillet M, et al,. (2011). Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ Res 108: 176-183.
123. Kelland NF, Webb DJ, (2006). Clinical trials of endothelin antagonists in heart failure: a question of dose? Exp Biol Med 231: 696-699.
124. Kelland NF, Webb DJ, (2007). Clinical trials of endothelin antagonists in heart failure: publication is good for the public health. Heart 93: 2-4.
125. Kelland NF, Kuc RE, McLean DL, Azfer A, Bagnall AJ, Gray GA, et al,. (2010). Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol 88: 644-651.
126. Kim Y, Phan D, van, Rooij E, Wang DZ, McAnally J, Qi X, et al,. (2008). The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest 118: 124-132.
127. Kirkby NS, Hadoke PWF, Bagnall AJ, Webb DJ, (2008). The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? Br J Pharmacol 153: 1105-1119.
128. Kobayashi T, Miyauchi T, Sakai S, Kobayashi M, Yamaguchi I, Goto K, et al,. (1999). Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart. Am J Physiol 276: H1197-H1206.
129. Kockskamper J, Seidlmayer L, Walther S, Hellenkamp K, Maier LS, Pieske B, (2008). Endothelin-1 enhances nuclear Ca2+ transients in atrial myocytes through Ins(1,4,5)P3-dependent Ca2+ release from perinuclear Ca2+ stores. J Cell Sci 121: 186-195.
130. Kockskämper J, Lewinski D, Khafaga M, Elgner A, Grimm M, Eschenhagen T, et al,. (2008a). The slow force response to stretch in atrial and ventricular myocardium from human heart: functional relevance and subcellular mechanisms. Prog Biophys Mol Biol 97: 250-267.
131. Kockskämper J, Zima AV, Roderick HL, Pieske B, Blatter LA, Bootman MD, (2008b). Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. J Mol Cell Cardiol 45: 128-147.
132. Kolettis TM, Baltogiannis GG, Tsalikakis DG, Tzallas AT, Agelaki MG, Fotopoulos A, et al,. (2008). Effects of dual endothelin receptor blockade on sympathetic activation and arrhythmogenesis during acute myocardial infarction in rats. Eur J Pharmacol 580: 241-249.
133. Komukai K, O-Uchi J, Morimoto S, Kawai M, Hongo K, Yoshimura M, et al,. (2010). Role of Ca(2+)/calmodulin-dependent protein kinase II in the regulation of the cardiac L-type Ca(2+) current during endothelin-1 stimulation. Am J Physiol 298: H1902-H1907.
134. Kuhn C, Frank D, Will R, Jaschinski C, Frauen R, Katus HA, et al,. (2009). DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy. J Biol Chem 284: 17320-17327.
135. Kurihara Y, Kurihara H, Oda H, Maemura K, Nagai R, Ishikawa T, et al,. (1995). Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest 96: 293-300.
136. Lakatta EG, Levy D, (2003a). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a 'set up' for vascular disease. Circulation 107: 139-146.
137. Lakatta EG, Levy D, (2003b). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 107: 346-354.
138. Lauer MR, Gunn MD, Clusin WT, (1992). Endothelin activates voltage-dependent Ca2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes. J Physiol (Lond) 448: 729-747.
139. Leblanc N, Hume JR, (1990). Sodium current-induced release of calcium from cardiac sarcoplasmic reticulum. Science 248: 372-376.
140. Lefkowitz RJ, Shenoy SK, (2005). Transduction of receptor signals by beta-arrestins. Science 308: 512-517.
141. Lenormand P, Sardet C, Pagès G, L'Allemain G, Brunet A, Pouyssegur J, (1993). Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J Cell Biol 122: 1079-1088.
142. Leslie SJ, Spratt JCS, McKee SP, Strachan FE, Newby DE, Northridge DB, et al,. (2005). Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure. Heart 91: 914-919.
143. Li X, Zima AV, Sheikh F, Blatter LA, Chen J, (2005). Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice. Circ Res 96: 1274-1281.
144. Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, Molkentin JD, (2001). The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 21: 7460-7469.
145. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, et al,. (2001). The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 98: 12283-12288.
146. Lim HW, Molkentin JD, (1999). Calcineurin and human heart failure. Nat Med 5: 246-247.
147. Lin AE, Alexander ME, Colan SD, Kerr B, Rauen KA, Noonan J, et al,. (2011). Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome. Am J Med Genet 155A: 486-507.
148. Lipp P, Laine M, Tovey SC, Burrell KM, Berridge MJ, Li W, et al,. (2000). Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart. Curr Biol 10: 939-942.
149. Lorenz K, Schmitt JP, Schmitteckert EM, Lohse MJ, (2009). A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat Med 15: 75-83.
150. Lu J, McKinsey TA, Nicol RL, Olson EN, (2000). Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 97: 4070-4075.
151. Mackenzie L, Bootman MD, Berridge MJ, Lipp P, (2001). Predetermined recruitment of calcium release sites underlies excitation-contraction coupling in rat atrial myocytes. J Physiol 530: 417-429.
152. Mackenzie L, Bootman MD, Laine M, Berridge MJ, Thuring J, Holmes A, et al,. (2002). The role of inositol 1,4,5-trisphosphate receptors in Ca(2+) signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol (Lond) 541: 395-409.
153. Mackenzie L, Roderick HL, Berridge MJ, Conway SJ, Bootman MD, (2004). The spatial pattern of atrial cardiomyocyte calcium signalling modulates contraction. J Cell Sci 117: 6327-6337.
154. McMullen JR, Jennings GL, (2007). Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 34: 255-262.
155. Maeda S, Tanabe T, Miyauchi T, Otsuki T, Sugawara J, Iemitsu M, et al,. (2003). Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J Appl Physiol 95: 336-341.
156. Maeda S, Jesmin S, Iemitsu M, Otsuki T, Matsuo T, Ohkawara K, et al,. (2006). Weight loss reduces plasma endothelin-1 concentration in obese men. Exp Biol Med (Maywood) 231: 1044-1047.
157. Maekawa N, Abe J-I, Shishido T, Itoh S, Ding B, Sharma VK, et al,. (2006). Inhibiting p90 ribosomal S6 kinase prevents (Na+)-H+ exchanger-mediated cardiac ischemia-reperfusion injury. Circulation 113: 2516-2523.
158. Markou T, Yong CS, Sugden PH, Clerk A, (2006). Regulation of protein kinase C delta by phorbol ester, endothelin-1, and platelet-derived growth factor in cardiac myocytes. J Biol Chem 281: 8321-8331.
159. Marshall AK, Barrett OP, Cullingford TE, Shanmugasundram A, Sugden PH, Clerk A, (2010). ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes. PLoS ONE 5: e10027.
160. Mayyas F, Niebauer M, Zurick A, Barnard J, Gillinov AM, Chung MK, et al,. (2010). Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol 3: 369-379.
161. Meyer M, Lehnart S, Pieske B, Schlottauer K, Munk S, Holubarsch C, et
162. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, et al,. (1993). Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526-538.
163. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, et al,. (1998). A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228.
164. Montessuit C, Thorburn A, (1999). Activation of Ras by phorbol esters in cardiac myocytes. Role of guanine nucleotide exchange factors. FEBS Lett 460: 57-60.
165. Moravec CS, Reynolds EE, Stewart RW, Bond M, (1989). Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 159: 14-18.
166. Moschella MC, Marks AR, (1993). Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes. J Cell Biol 120: 1137-1146.
167. Moschella PC, Rao VU, McDermott PJ, Kuppuswamy D, (2007). Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCÎμ and PKCÎ, in adult cardiac muscle cells. J Mol Cell Cardiol 43: 754-766.
168. Motte S, van Beneden R, Mottet J, Rondelet B, Mathieu M, Havaux X, et al,. (2003). Early activation of cardiac and renal endothelin systems in experimental heart failure. Am J Physiol 285: H2482-H2491.
169. Munzel F, Muhlhauser U, Zimmermann W-H, Didié M, Schneiderbanger K, Schubert P, et al,. (2005). Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition. Cardiovasc Res 68: 464-474.
170. Nag AC, (1980). Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 28: 41-61.
171. Nagasaka T, Izumi M, Hori M, Ozaki H, Karaki H, (2003). Positive inotropic effect of endothelin-1 in the neonatal mouse right ventricle. Eur J Pharmacol 472: 197-204.
172. Nakayama H, Bodi I, Maillet M, DeSantiago J, Domeier TL, Mikoshiba K, et al,. (2010). The IP3 receptor regulates cardiac hypertrophy in response to select stimuli/novelty and significance. Circ Res 107: 659-666.
173. Neal JW, Clipstone NA, (2001). Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J Biol Chem 276: 3666-3673.
174. Nemoto S, Sheng Z, Lin A, (1998). Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol 18: 3518-3526.
175. Nishida K, Yamaguchi O, Hirotani S, Hikoso S, Higuchi Y, Watanabe T, et al,. (2004). p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol Cell Biol 24: 10611-10620.
176. Nishimaru K, Miura Y, Endoh M, (2007). Mechanisms of endothelin-1-induced decrease in contractility in adult mouse ventricular myocytes. Br J Pharmacol 152: 456-463.
177. Nunez DJ, Brown MJ, Davenport AP, Neylon CB, Schofield JP, Wyse RK, (1990). Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest 85: 1537-1541.
178. Omura T, Yoshiyama M, Yoshida K, Nakamura Y, Kim S, Iwao H, et al,. (2002). Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine. Hypertension 39: 81-86.
179. Ono K, Tsujimoto G, Sakamoto A, Eto K, Masaki T, Ozaki Y, et al,. (1994). Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 370: 301-304.
180. Ono K, Masumiya H, Sakamoto A, Christé G, Shijuku T, Tanaka H, et al,. (2001). Electrophysiological analysis of the negative chronotropic effect of endothelin-1 in rabbit sinoatrial node cells. J Physiol (Lond) 537: 467-488.
181. Palaniyandi SS, Sun L, Ferreira JC, Mochly-Rosen D, (2009). Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res 82: 229-239.
182. Park A-M, Wong C-M, Jelinkova L, Liu L, Nagase H, Suzuki YJ, (2010). Pulmonary hypertension-induced GATA4 activation in the right ventricle. Hypertension 56: 1145-1151.
183. Peng Y, Lambert AA, Papst P, Pitts KR, (2009). Agonist-induced nuclear export of GFP-HDAC5 in isolated adult rat ventricular myocytes. J Pharmacol Toxicol Methods 59: 135-140.
184. Perez PJ, Ramos-Franco J, Fill M, Mignery GA, (1997). Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J Biol Chem 272: 23961-23969.
185. Petkova SB, Tanowitz HB, Magazine HI, Factor SM, Chan J, Pestell RG, et al,. (2000). Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol 9: 257-265.
186. Petrich BG, Eloff BC, Lerner DL, Kovacs A, Saffitz JE, Rosenbaum DS, et al,. (2004). Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J Biol Chem 279: 15330-15338.
187. Phan D, Stratton MS, Huynh QK, McKinsey TA, (2011). A novel protein kinase C target site in protein kinase D is phosphorylated in response to signals for cardiac hypertrophy. Biochem Biophys Res Commun 411: 335-341.
188. Philipson KD, Nicoll DA, (2000). Sodium-calcium exchange: a molecular perspective. Annu Rev Physiol 62: 111-133.
189. Pi Y, Zhang D, Kemnitz KR, Wang H, Walker JW, (2003). Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium. J Physiol (Lond) 552: 845-857.
190. Pieske B, Schlotthauer K, Schattmann J, Beyersdorf F, Martin J, Just H, et al,. (1997). Ca(2+)-dependent and Ca(2+)-independent regulation of contractility in isolated human myocardium. Basic Res Cardiol 92 (Suppl. 1): 75-86.
191. Pieske B, Beyermann B, Breu V, Loffler BM, Schlotthauer K, Maier LS, et al,. (1999). Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99: 1802-1809.
192. Pikkarainen S, Tokola H, Kerkela R, Ilves M, Mäkinen M, Orzechowski H-D, et al,. (2006). Inverse regulation of preproendothelin-1 and endothelin-converting enzyme-1beta genes in cardiac cells by mechanical load. Am J Physiol Regul Integr Comp Physiol 290: R1639-R1645.
193. Ping P, Anzai T, Gao M, Hammond HK, (1997). Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol 273: H707-H717.
194. Proven A, Roderick HL, Conway SJ, Berridge MJ, Horton JK, Capper SJ, et al,. (2006). Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J Cell Sci 119: 3363-3375.
195. Puri TS, Gerhardstein BL, Zhao XL, Ladner MB, Hosey MM, (1997). Differential effects of subunit interactions on protein kinase A- and C-mediated phosphorylation of L-type calcium channels. Biochemistry 36: 9605-9615.
196. Remus TP, Zima AV, Bossuyt J, Bare DJ, Martin JL, Blatter LA, et al,. (2006). Biosensors to measure inositol 1,4,5-trisphosphate concentration in living cells with spatiotemporal resolution. J Biol Chem 281: 608-616.
197. Rinne A, Blatter LA, (2010). Activation of NFATc1 is directly mediated by IP3 in adult cardiac myocytes. Am J Physiol 299: H1701-H1707.
198. Rinne A, Kapur N, Molkentin JD, Pogwizd SM, Bers DM, Banach K, et al,. (2010). Isoform- and tissue-specific regulation of the Ca2+-sensitive transcription factor NFAT in cardiac myocytes and heart failure. Am J Physiol 298: H2001-H2009.
199. Robu VG, Pfeiffer ES, Robia SL, Balijepalli RC, Pi Y, Kamp TJ, et al,. (2003). Localization of functional endothelin receptor signaling complexes in cardiac transverse tubules. J Biol Chem 278: 48154-48161.
200. Roderick HL, Berridge MJ, Bootman MD, (2003). Calcium-induced calcium release. Curr Biol 13: R425.
201. Rubart M, Field LJ, (2006). Cardiac regeneration: repopulating the heart. Annu Rev Physiol 68: 29-49.
202. Russell FD, Davenport AP, (1996). Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol 119: 631-636.
203. Russell FD, Molenaar P, (2000). The human heart endothelin system: ET-1 synthesis, storage, release and effect. Trends Pharmacol Sci 21: 353-359.
204. Sadoshima J, Xu Y, Slayter HS, Izumo S, (1993). Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984.
205. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y, (1996). Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384: 353-355.
206. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al,. (1990). Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735.
207. Salazar NC, Chen J, Rockman HA, (2007). Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim Biophys Acta 1768: 1006-1018.
208. Salomone OA, Caeiro TF, Madoery RJ, Amuchástegui M, Omelinauk M, Juri D, et al,. (2001). High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am J Cardiol 87: 1217-1220; A7.
209. Sanna B, Bueno OF, Dai YS, Wilkins BJ, Molkentin JD, (2005). Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Mol Cell Biol 25: 865-878.
210. Selvais PL, Robert A, Ahn S, van, Linden F, Ketelslegers JM, Pouleur H, et al,. (2000). Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail 6: 201-207.
211. Serneri GGN, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A, et al,. (2000). Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. Circ Res 86: 377-385.
212. Shah AM, Lewis MJ, Henderson AH, (1989). Inotropic effects of endothelin in ferret ventricular myocardium. Eur J Pharmacol 163: 365-367.
213. Shattock MJ, Bers DM, (1989). Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes. Am J Physiol 256: C813-C822.
214. Shaw KT, Ho AM, Raghavan A, Kim J, Jain J, Park J, et al,. (1995). Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci USA 92: 11205-11209.
215. Shibasaki F, Price ER, Milan D, McKeon F, (1996). Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382: 370-373.
216. Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, et al,. (2008). Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205: 295-303.
217. Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, et al,. (2004a). Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15: 2707-2719.
218. Shi-Wen X, Howat SL, Renzoni EA, Holmes A, Pearson JD, Dashwood MR, et al,. (2004b). Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem 279: 23098-23103.
219. Shohet RV, Kisanuki YY, Zhao XS, Siddiquee Z, Franco F, Yanagisawa M, (2004). Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy. Proc Natl Acad Sci USA 101: 2088-2093.
220. Smyrnias I, Mair W, Harzheim D, Walker SA, Roderick HL, Bootman MD, (2010). Comparison of the T-tubule system in adult rat ventricular and atrial myocytes, and its role in excitation-contraction coupling and inotropic stimulation. Cell Calcium 47: 210-223.
221. Snabaitis AK, Muntendorf A, Wieland T, Avkiran M, (2005). Regulation of the extracellular signal-regulated kinase pathway in adult myocardium: differential roles of G(q/11), Gi and G(12/13) proteins in signalling by alpha1-adrenergic, endothelin-1 and thrombin-sensitive protease-activated receptors. Cell Signal 17: 655-664.
222. Snabaitis AK, Cuello F, Avkiran M, (2008). Protein kinase B/Akt phosphorylates and inhibits the cardiac Na+/H+ exchanger NHE1. Circ Res 103: 881-890.
223. Song L-S, Sobie EA, McCulle S, Lederer WJ, Balke CW, Cheng H, (2006). Orphaned ryanodine receptors in the failing heart. Proc Natl Acad Sci USA 103: 4305-4310.
224. Sugden PH, (2003). An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 35: 871-886.
225. Sugden PH, Clerk A, (2006). Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes. Antioxid Redox Signal 8: 2111-2124.
226. Sutsch G, Kiowski W, Yan XW, Hunziker P, Christen S, Strobel W, et al,. (1998). Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98: 2262-2268.
227. Suzuki T, Kumazaki T, Mitsui Y, (1993). Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 191: 823-830.
228. Swynghedauw B, (1999). Molecular mechanisms of myocardial remodeling. Physiol Rev 79: 215-262.
229. Tachibana H, Perrino C, Takaoka H, Davis RJ, Naga Prasad SV, Rockman HA, (2006). JNK1 is required to preserve cardiac function in the early response to pressure overload. Biochem Biophys Res Commun 343: 1060-1066.
230. Tadevosyan A, Maguy A, Villeneuve LR, Babin J, Bonnefoy A, Allen BG, et al,. (2010). Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem 285: 22338-22349.
231. Tadevosyan A, Vaniotis G, Allen BG, Hébert TE, Nattel S, (2012). G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function. J Physiol (Lond) 590: 1313-1330.
232. Takanashi M, Endoh M, (1991). Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 261: H611-H619.
233. Takuwa Y, Kasuya Y, Takuwa N, Kudo M, Yanagisawa M, Goto K, et al,. (1990). Endothelin receptor is coupled to phospholipase C via a pertussis toxin-insensitive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells. J Clin Invest 85: 653-658.
234. Tanowitz HB, Huang H, Jelicks LA, Chandra M, Loredo ML, Weiss LM, et al,. (2005). Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 73: 2496-2503.
235. Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, Van Den Berg MP, De Kam PJ, Crijns HJ, (1998). Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 81: 1207-1210.
236. Uchida K, Aramaki M, Nakazawa M, Yamagishi C, Makino S, Fukuda K, et al,. (2010). Gene knock-outs of inositol 1,4,5-trisphosphate receptors types 1 and 2 result in perturbation of cardiogenesis. PLoS ONE 5: e12500.
237. Ueyama T, Kawashima S, Sakoda T, Rikitake Y, Ishida T, Kawai M, et al,. (2000). Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J Mol Cell Cardiol 32: 947-960.
238. Vaniotis G, Allen BG, Hébert TE, (2011a). Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling. Am J Physiol 301: H1754-H1764.
239. Vaniotis G, Del Duca D, Trieu P, Rohlicek CV, Hébert TE, Allen BG, (2011b). Nuclear β-adrenergic receptors modulate gene expression in adult rat heart. Cell Signal 23: 89-98.
240. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, et al,. (2004). Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24: 8374-8385.
241. Vigne P, Lazdunski M, Frelin C, (1989). The inotropic effect of endothelin-1 on rat atria involves hydrolysis of phosphatidylinositol. FEBS Lett 249: 143-146.
242. Vijayan K, Szotek EL, Martin JL, Samarel AM, (2004). Protein kinase C-alpha-induced hypertrophy of neonatal rat ventricular myocytes. Am J Physiol 287: H2777-H2789.
243. Vinge LE, Oie E, Andersson Y, GrÃgaard HK, Andersen G, Attramadal H, (2001). Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. Am J Physiol 281: H2490-H2499.
244. Vinge LE, Andressen KW, Attramadal T, Andersen GO, Ahmed MS, Peppel K, et al,. (2007). Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function. Mol Pharmacol 72: 582-591.
245. Wang H, Grant JE, Doede CM, Sadayappan S, Robbins J, Walker JW, (2006). PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144. J Mol Cell Cardiol 41: 823-833.
246. Wang J, Paradis P, Aries A, Komati H, Lefebvre C, Wang H, et al,. (2005). Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol 25: 9829-9844.
247. Wang JX, Paik G, Morgan JP, (1991). Endothelin 1 enhances myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium. Circ Res 69: 582-589.
248. Wang QD, Gonon A, Shimizu M, Sjöquist PO, Pernow J, (1998). Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition. Acta Physiol Scand 163: 325-330.
249. Watanabe T, Endoh M, (1999). Characterization of the endothelin-1-induced regulation of L-type Ca2+ current in rabbit ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 360: 654-664.
250. Watts SW, (2010). Endothelin receptors: what's new and what do we need to know. Am J Physiol Regul Integr Comp Physiol 298: R254-R260.
251. Webb DJ, (1991). Endothelin receptors cloned, endothelin converting enzyme characterized and pathophysiological roles for endothelin proposed. Trends Pharmacol Sci 12: 43-46.
252. Westfall MV, Lee AM, Robinson DA, (2005). Differential contribution of troponin I phosphorylation sites to the endothelin-modulated contractile response. J Biol Chem 280: 41324-41331.
253. Wilkins BJ, De Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF, et al,. (2002). Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol 22: 7603-7613.
254. Wright CD, Wu SC, Dahl EF, Sazama AJ, O'Connell TD, (2012). Nuclear localization drives α1-adrenergic receptor oligomerization and signaling in cardiac myocytes. Cell Signal 24: 794-802.
255. Wu DQ, Lee CH, Rhee SG, Simon MI, (1992). Activation of phospholipase C by the alpha subunits of the Gq and G11 proteins in transfected Cos-7 cells. J Biol Chem 267: 1811-1817.
256. Wu ML, Tseng YZ, (1993). The modulatory effects of endothelin-1, carbachol and isoprenaline upon Na(+)-H+ exchange in dog cardiac Purkinje fibres. J Physiol (Lond) 471: 583-597.
257. Wu X, Zhang T, Bossuyt J, Li X, McKinsey TA, Dedman JR, et al,. (2006). Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116: 675-682.
258. Wu X, Simpson J, Hong JH, Kim K-H, Thavarajah NK, Backx PH, et al,. (2011). MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation. J Clin Invest 121: 1009-1025.
259. Xu M, Zhou P, Xu SM, Liu Y, Feng X, Bai SH, et al,. (2007). Intermolecular failure of L-type Ca2+ channel and ryanodine receptor signaling in hypertrophy. Plos Biol 5: e21.
260. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, et al,. (1996). Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem 271: 3221-3228.
261. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al,. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
262. Yang HT, Sakurai K, Sugawara H, Watanabe T, Norota I, Endoh M, (1999). Role of Na+/Ca2+ exchange in endothelin-1-induced increases in Ca2+ transient and contractility in rabbit ventricular myocytes: pharmacological analysis with KB-R7943. Br J Pharmacol 126: 1785-1795.
263. Yang LL, Gros R, Kabir MG, Sadi A, Gotlieb AI, Husain M, et al,. (2004). Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 109: 255-261.
264. Yorikane R, Sakai S, Miyauchi T, Sakurai T, Sugishita Y, Goto K, (1993). Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett 332: 31-34.
265. Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC, et al,. (2000). Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem 275: 37895-37901.
266. Zhai P, Gao S, Holle E, Yu X, Yatani A, Wagner T, et al,. (2007). Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases. J Biol Chem 282: 33181-33191.
267. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN, (2002). Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110: 479-488.
268. Zhang S, Weinheimer C, Courtois M, Kovacs A, Zhang CE, Cheng AM, et al,. (2003). The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J Clin Invest 111: 833-841.
269. Zhang W, Anger T, Su J, Hao J, Xu X, Zhu M, et al,. (2006). Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. J Biol Chem 281: 5811-5820.
270. Zhang YH, Hancox JC, (2009). Regulation of cardiac Na+-Ca2+ exchanger activity by protein kinase phosphorylation-still a paradox? Cell Calcium 45: 1-10.
271. Zhao X-S, Pan W, Bekeredjian R, Shohet RV, (2006). Endogenous endothelin-1 is required for cardiomyocyte survival in vivo. Circulation 114: 830-837.
272. Zhou P, Zhao Y-T, Guo Y-B, Xu S-M, Bai S-H, Lakatta EG, et al,. (2009). Beta-adrenergic signaling accelerates and synchronizes cardiac ryanodine receptor response to a single L-type Ca2+ channel. Proc Natl Acad Sci USA 106: 18028-18033.
273. Zhu W, Zou Y, Shiojima I, Kudoh S, Aikawa R, Hayashi D, et al,. (2000). Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J Biol Chem 275: 15239-15245.
274. Zima AV, Bare DJ, Mignery GA, Blatter LA, (2007). IP3-dependent nuclear Ca2+ signalling in the mammalian heart. J Physiol 584: 601-611.
275. Zolk O, Quattek J, Seeland U, El-Armouche A, Eschenhagen T, Böhm M, (2002). Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats. Cardiovasc Res 53: 363-371.